Card image cap

Chris Smith's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Republican for U.S. House (NJ) - District 4

Page 1 of 2

Date Title
10/07/2022 Smith pushes new legislation to combat deadly fentanyl pouring across US border
04/28/2020 $2M More for Mental Health & Substance Abuse Grants for Ocean & Monmouth Counties
05/10/2019 Letter to the Hon. Norma Sharpless, Acting Commissioner of the Food and Drug Administration - Reps. Burgess and Roby Urge Continued FDA Oversight of Mail-Order Abortion Drugs
04/11/2019 Smith Introduces Legislation to Close Road Safety/Drug Testing Loophole
04/01/2019 On China's Announcement to List All Fentanyl Variants on Its Controlled Substances List
03/05/2019 Smith Introduces New Legislation to Combat Deadly Chinese Fentanyl
10/26/2018 Smith Bill Aims to Combat Deadly Threat of Chinese Fentanyl
10/05/2018 NJ Fraternal Order of Police Endorses Rep. Chris Smith
09/29/2018 TAP into - Combating the Scourge of the Opioid Epidemic
06/15/2018 Combating Opioid Addiction; Advancing Treatment
12/11/2017 Letter to the Hon. Mick Mulvaney, Director of Office of Management and Budget - Additional Federal Opioid Relief
11/30/2016 Congressman Smith Supports 'Once-in-a-Generation' Opportunity to Bring Treatments to Patients in Need
10/14/2016 Letter to the Hon. Andrew Slavitt, Acting Administrator, Centers for Medicare and Medicaid Services - Expanded Substance Abuse Treatment Coverage to Combat Opioid Crisis
05/10/2016 Smith Supports Legislative Package to Combat Prescription and Illegal Drug Abuse
04/26/2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA) - Sen. Cruz, Others Hammer FDA on Relaxed Standards for Abortion Drug
04/23/2013 Smith Chairs Health Hearing on 'Superbugs' that Resist Drug Treatment
08/13/2010 Congressman Smith Comments on FDA Approval of Abortion Drug 'ella'
11/19/2007 Smith: First Responders Are Critical to Effort to Counter Meth Production
03/29/2007 The Global Threat Of Drug-Resistant TB
08/24/2006 Rep. Smith: FDA's Morning-After Pill Decision Dangerous Medicine for Women and Girls
04/11/2006 Seniors Taking Advantage of Medicare Drug Choices
03/17/2006 Smith Urges Passage of Holly's Law After RU-486 is Linked to Additional Deaths of Women
02/01/2006 Smith Joins Colleagues in Urging Passage of Holly's Law
08/16/2005 CDC Investigation a Sad Reminder that RU-486 Continues to Endanger Women
05/03/2005 Health Risks Associated with Inhaled Compounded Drugs Used in Nebulizers

Page 1 of 2
arrow_upward